A Conversation On The Biopharma Cold Chain
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics, an allogeneic T-cell immunotherapy company developing therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases, provides his thoughts on the cold chain (temperature range of 2℃ to 8℃) and ultra-cold chain (-90℃ and -60℃) systems for transporting temperature sensitive biopharmaceuticals.
This website uses cookies to ensure you get the best experience on our website. Learn more